History of permanent pacing

1. Wikipedia Foundation, Inc. Artificial Pacemaker

<http: //en.wikipedia.org/wiki/Artificial_pacemaker>

2. Elmqvist R, Senning Å. Implantable pacemaker for the heart. In: Smyth CN (ed). Medical Electronics: Proceedings of the Second International Conference on Medical Electronics, Paris, 24–27 June 1959. London: Iliffe & Sons 1960: 253–254.

3. Larsson B, Elmqvist H, Ryden L, Schuller H. Lessons from the first patient with an implanted pacemaker: 1958-2001. Pacing Clin Electrophysiol 2003; 26: 114-24.

4. Schwedel JB, Furman S, Escher DJW. Use of an Intracardiac Pacemaker in the treatment of Stokes-Adams Seizures. Prog Cardiovasc Dis 1960; 3: 170-177.

5. Glenn WWL, Mauro A, Longo E et al. The Radiofrequency Cardiac Pacemaker. Remote stimulation of the heart by radiofrequency transmission. Clinical application to a patient with Stoke-Adams Syndrome. New Engl J Med 1959; 262: 948-951.

6. Fiandra O. The First Pacemaker Implant in America. PACE 1988; 11: 1234-1238.

7. Ruben S. Sealed Zinc-Mercuric Oxide Cells for Implantable Cardiac Pacemakers. Ann NY Acad Sci 1969; 167: 627-634.

8. Chardack WM, Gage AA, Greatbatch W. A transistorized, selfcontained, implantable pacemaker for the long-term correction of complete heart block. Surgery 1960; 48: 643– 654.

9. Zoll PM, Frank HA, Zarsky LRN, Linenthal AJ, Belgard AH. Long-term electric stimulation of the heart for Stokes-Adams disease. Ann Surg 1961; 154: 330–346.

10. Greatbatch W. Implantable Active Devices: A Series of Twelve Monographs Commemorating the Twenty-Fifth Anniversary of the First Implantable Cardiac Pacemaker, No. 2: Pulse Generator Design. Clarence, NY: Greatbatch Enterprises 1983.

11. Chardack WM. Heart-block treated with an implantable pacemaker: past experience and current developments. In: Shaw G, Smith G, Thomson TJ (eds). Resuscitation and Cardiac Pacing. Philadelphia: FA Davis 1965: 213–249.

12. Chardack WM, Gage AA, Federico AJ et al. Clinical experience with an implantable pacemaker. Ann N Y Acad Sci 1964; 111: 1075–1092.

13. Kantrowitz A. Implantable cardiac pacemakers. Ann N Y Acad Sci 1964; 111: 1049–1067.

14. Parsonnet V, Gilbert L, Zucker IR, Asa MM. Complications of the implanted pacemaker: a scheme for determining the cause of the defect and methods for correction. J Thorac Cardiovasc Surg 1963; 45: 801–812.

15. Ruben S. Sealed zinc-mercuric oxide cells for implantable cardiac pacemakers. Ann N Y Acad Sci. 1969; 167: 627–634.

16. Parsonnet V. Power sources for implantable cardiac pacemakers. Chest 1972; 61: 165–173.

17. Parsonnet V, Myers G, Zucker IR, Lotman H. The potentiality of the use of biologic energy as a power source for implantable pacemakers. Ann N Y Acad Sci 1964; 111: 915–921.

18. Lewin G, Myers GH, Parsonnet V, Raman KV. An improved biological power source for cardiac pacemakers. Trans Am Soc Artif Intern Org 1968; 14: 215–219.

19. Zucker IR, Parsonnet V, Myers GH, Lotman H, Asa MM. Self-energized pacemakers: the possibilities of using biological energy sources. Circulation 1964; 29: 157–160.

20. Jeffrey K, Parsonnet V. Cardiac Pacing, 1960-1985. A Quarter Century of Medical and Industrial Innovation. Circ 1998; 97: 1978-1991.

21. Nathan DA, Center S, Wu C-Y, Keller JW. An implantable synchronous pacemaker for long-term correction of complete heart block. Circulation 1963; 27: 682–685.

22. Keller JW. Atrial and ventricular synchrony: the engineering-physiology interface. Ann N Y Acad Sci 1969; 167: 869–885.

23. Furman S. Therapeutic uses of atrial pacing. Am Heart J 1973; 73: 835–840.

24. Castellanos A, Maytin O, Lemberg L, Berkovits BV. Part VIII. Rhythm Disturbances and Pacing: Pacemaker induced cardiac rhythm disturbances. Ann NY Acad Sci 1969; 903-910.

25. Sykosch HJ, Effert S, Pulver KG, Zacouto F. Zur Therapie mit elektrischen Schrittmachern. Ein implantierbarer, induktiv ausschaltbarer elektrisher Schrittmacher. Elektromedizin 1963; 8: 139–142.

26. Zuckerman W, Zaroff LI, Berkovits BV et al. Clinical experiences with a new implantable demand pacemaker. Am J Cardiol 1967; 20: 232–238.

27. Parsonnet V, Zucker IR, Gilbert L, Myers GH. Clinical use of an implantable standby pacemaker. JAMA 1966; 196: 784–786.

28. Lemberg C, Castellanos A Jr, Berkovits BV. Bifocal demand pacemaker. Circulation 1969; 40(suppl III): III-44. Abstract.

29. Castillo CA, Berkovits BV, Castellanos A Jr et al. Bifocal demand pacing. Chest 1971; 59: 360–364.

30. Furman S, Robinson G. Use of an intracardiac pacemaker in the correction of total heart block. Surg Forum. 1958; 9: 245–248.

31. Furman S. Recollections of the beginning of transvenous cardiac pacing. PACE Pacing Clin Electrophysiol 1994; 17: 1697–1705.

32. Parsonnet V, Zucker IR, Asa MM. Preliminary investigation of the development of a permanent implantable pacemaker utilizing an intracardiac dipolar electrode. Clin Res 1962; 10: 391.

33. Lagergren H, Johansson L. Intracardiac stimulation for complete heart block. Acta Chir Scand 1963; 125: 562–566.

34. Lagergren H, Johansson L, Landegren J, Edhag O. One hundred cases of treatment for Adams-Stokes syndrome with permanent intravenous pacemaker. J Thorac Cardiovasc Surg 1965; 5: 710–714.

35. Parsonnet V, Gilbert L, Zucker IR, Asa MM. A plan for the treatment of complete heart block and Stokes-Adams syndrome with an intracardiac dipolar electrode and a permanent implantable pacemaker. Angiology 1963; 14: 343–348.

36. Parsonnet V. A decade of permanent pacing of the heart. Cardiovasc Clin 1970; 2: 182–199.

37. Fejfar Z. Peleška a Pelešovci aneb kardiostimulace v Krči. Cor Vasa 1996; 35(1): K12-K15.

38. Parsonnet V. Cardiac pacing and pacemakers, VII: power sources for pacemakers. Am Heart J 1977; 94: 517–528, 658–664.

39. Laurens P. Nuclear-powered pacemakers: an eight-year clinical experience. PACE Pacing Clin Electrophysiol 1979; 2: 356–360.

40. Parsonnet V. Clinical experience with nuclear pacemakers. Surgery 1975; 78: 776–786.

41. Sowton E. Energy sources for pacemakers. In: Watanabe Y (ed). Proceedings of the Vth International Symposium, Tokyo, March 14–18, 1975. Amsterdam: Excerpta Medica 1977: 438–446.

42. Friedberg HD, Lillehei RC. Long-life pacemakers: 3-year study of Cardiac Pacemakers, Inc., lithium pulse generators. In: Watanabe Y (ed). Proceedings of the Vth International Symposium, Tokyo, March 14–18, 1975. Amsterdam: Excerpta Medica 1977: 471– 473.

43. Greatbatch W. Interview. In: Brown KA. Inventors at Work. Redmond, Wash: Tempus Books 1988: 19–44.

44. Greatbatch W. Achieving reliable pacemakers. In: Watanabe Y (ed). Proceedings of the Vth International Symposium, Tokyo, March 14–18, 1976. Amsterdam: Excerpta Medica 1977: 364–368.

45. Bowers DL. New pacemaker devices from a technical point of view. In: Thalen HJT, Harthorne JW (eds). To Pace or Not to Pace: Controversial Subjects in Cardiac Pacing. Hague: M Nijhoff 1978: 126–130.

46. Parsonnet V, Bernstein AD, Perry GY.The nuclear pacemaker: Is renewed interest warranted. Am J Cardiol 1990; 66: 837-842.

47. Ferrer MI. The sick sinus syndrome in atrial disease. JAMA 1968; 206: 645–646.

48. Cardiac care competitors continue crowding. Biomed Insight 1973; 4: 187–190.

49. Ohm OJ, Bruland H, Pedersen OM, Waerness E. Interference Effect of Myopotentials on Function of Unipolar Demand Pacemakers. Brit Heart J 1974; 36: 77-84.

50. Parsonnet V, Cuddy TE, Escher DJW et al. A permanent pacemaker capable of external non-invasive programming. Trans Am Soc Artif Intern Org 1973; 19: 224–228.

51. Tyers FO, Brownlee RR. A multiparameter telemetry system for cardiac pacemakers. In: Varriale P, Naclerio EA (eds). Cardiac Pacing: A Concise Guide to Clinical Practice. Philadelphia: Lea & Febiger 1979: 349–368.

52. Mugica J, Lazarus B, Buffet J, Catte M. Pacemaker with automatic adaptation to the pacing threshold. In: Thalen HJT (ed). „Cardiac Pacing“. Assen: Van Gorcum & Comp. B.V. 1973: 150-155.

53. Ribeiro ALP, Rincon LG, Oliveira BG et al. Automatic Adjustment of Pacing Output in the Clinical Setting. Am Heart J 2004: 147(1): 127-131.

54. Griffin JC, Quitman JA. Pacemaker programmability: the role of noninvasive pacing system revision. In: Meere C (ed). Proceedings of the VIth World Symposium on Cardiac Pacing. Montreal: PACESYMP 1979.

55. Parsonnet V, Rodgers T. The present status of programmable pacemakers. Prog Cardiovasc Dis 1981; 4: 401– 420.

56. MacGregor DC, Furman S, Dreifus LS, Cuddy TE. The utility of the programmable pacemaker. PACE Pacing Clin Electrophysiol 1978; 1: 254–259. Panel discussion.

57. Mandel WJ,Yamaguchi I, Laks M, Berkovits B. The use of overdrive pacing for termination of tachycardia episodes in the Wolff-Parkinson-White (WPW) syndrome. In: Watanabe Y (ed). Cardiac Pacing: ProcV International Symposium. Tokyo,1976. Amsterdam: Excerpta Medica 1977; 162-165.

58. Dreifus LS, Ogawa S, Watanabe Y et al. Effect of Multiple Simultaneous Activation Sites (Biventricular Pacing) on Ventricular Depolarization and Ventricular Arrhythmias. In: Watanabe Y (ed). Cardiac Pacing. Proceedings of the Vth International Symposium Tokyo, March 14-18, 1976. Amsterdam: Excerpta Medica 1977: 33-39.

59. Parsonnet V, Furman S, Smyth NPD. Implantable cardiac pacemakers; Status report and resource guideline. Pacemaker Study Group, Inter-Society Commission for Heart Disease Resources (ICHD). Circulation 1974; 50: A21-A35.

60. Parsonnet V. Routine implantation of permanent transvenous pacemaker electrodes in both chambers: a technique whose time has come. PACE Pacing Clin Electrophysiol 1981; 4: 109–112.

61. Smyth N, Vasarhelyi L, McNamara W, Kakascik, GE. A permanent transvenous atrial electrode catheter. J Thorac Cardiovasc Surg 1969; 58: 773–782.

62. Smyth N, Citron P, Keshishian J et al. Permanent pervenous atrial sensing and pacing with a new J shaped lead. J Thorac Cardiovasc Surg 1976; 72: 565–570.

63. Painter MW, Harrington OB, Crosby VG, Wolf RY. Implantation of an endocardial tined lead to prevent early dislodgment. J Thorac Cardiovasc Surg 1979; 77(2): 249-251.

64. Robicsek F, Tarjan P, Harbold NB. Self-anchoring endocardial pacemaker leads: current spectrum of types, advances in design, and clinical results. Am Heart J 1981; 102: 775–782.

65. Scheuer-Leeser M, Irnich W, Kreuzer J. Polyurethane leads: facts and controversy. PACE Pacing Clin Electrophysiol 1983; 6: 454–458.

66. Littleford PO, Parsonnet V, Spector SD. Method for the rapid and atraumatic insersion of permanent endocardial pacemaker electrodes through the subclavian vein. Am J Cardiol 1979; 43: 980–982.

67. Furman S. Physiologic pacing. PACE Pacing Clin Electrophysiol 1980; 3: 639–640.

68. Furman S, Fisher JD. Endless loop tachycardia in an AV universal (DDD) pacemaker. PACE Pacing Clin Electrophysiol 1982; 5: 486–489.

69. Bernstein AD, Parsonnet V. Engineering aspects of pulse generators for cardiac pacing. In: Saksena S, Goldschlager N (eds). Electrical Therapy for Cardiac Arrhythmias. Philadelphia: WB Saunders Co 1990: 21–34.

70. Parsonnet V, Escher DJW, Furman S et al. Indications for dual-chamber pacing. PACE Pacing Clin Electrophysiol 1984; 7: 318–319.

71. Mond H, Stokes K, Helland J et al. The Porous Titanium Steroid Eluting Electrode: A Double Blind Study Assessing the Stimulation Threshold Effects of Steroid. PACE 1988; 11: 214-219.

72. Physiological principles of a new method for rate responsive pacing using the pre-ejection interval. PACE 1988; 11: 1545-1554.

73. Mirowski M, Mower MM, Reid PR. The Automatic Implantable Defibrillator. American Heart Journal 1980; 100: 1089-1092.

74. Mirowski M, Reid PR, Mower MM et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980; 303(6): 322-324.

75. Naccarelli GV, Dougherty AH. Unit 7, Implantable cardioverter-defibrillators. In: Naccarelli GV (ed). EPSAP (Electrophysiology self-assessment program). Bethesda: American College of Cardiology 1996.

76. Luderitz B, Gerckens U, Manz M. Automatic implantable cardioverter / defibrillator (AICD) and antitachycardia pacemaker (Tachylog): Combined use in ventricular tachyarrhythmias. PACE 1986; 9: 1356-1360.

77. Bardy GH, Johnson G, Poole JE, Dolack GL et al. A simplified, single lead unipolar transvenous cardioverter-defibrillator. Circulation 1993; 88: 543-547.

78. Parsonnet V, Furman S, Smyth NPD. A revised code for pacemaker identification. PACE 1981; 4: 400-403.

79. Bernstein AD, Brownlee RR, Fletcher R et al. Report of the NASPE Mode Code Committee. PACE 1984; 7: 395-402.

80. Bernstein AD, Camm AJ, Fletcher R et al. The NASPE/BPEG Pacemaker Code for antibradyarrhythmia and adaptive-rate pacing and antitachyarrhythmia devices. PACE 1987; 10: 794-799.

81. Bernstein AD, Camm AJ, Fisher JD et al. The NASPE/BPEG Defibrillator Code. PACE 1993; 16: 1776-1780.

82. Bernstein AD, Parsonnet V. The NASPE/BPEG Pacemaker-Lead Code. PACE 1996; 19: 1535-1536.

83. Bernstein AD, Daubert JC, Fletcher RD et al. The Revised NASPE/BPEG Generic Code for antibradycardia, adaptive-rate, and multisite pacing. PACE 2000; 25: 260-264.

84. Daubert JC. Biatrial Synchronous Pacing: Opening the Way to Cardiac Resynchronization Therapy . Eur Heart J 1991. PROSÍM AUTORY O DOPLNĚNÍ ÚDAJŮ

85. Petersen MEV, Sutton R. Cardiac pacing for vasovagal syncope: a reasonable therapeutic option? Pacing Clin Electrophysiol 1997; 20: 824–826.

86. Gadler F, Linde C, Daubert C et al. Significant improvement of quality of life following atrioventricular synchronous pacing in patients with hypertrophic obstructive cardiomyopathy. Eur Heart J 1999; 20(14): 1044–1050.

87. Kuck KH, Cappato R, Siebels J et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The cardiac arrest study Hamburg (CASH). Circulation 2000; 102: 748–54.

88. Andersen JL, Hallstrom AP, Epstein AE et al. Design and results of the antiarrhythmics vs. implantable defibrillators (AVID) registry. The AVID Investigators Circulation 1999; 99: 1692-1699.

89. Connoly SJ, Gillis AM, Lacombe P et al. Canadian Implantable Defibrillator Study (CIDS). Circulation 2000; 101: 1297–1302.

90. Bokhari F, Newman D, Greene M et al. Long-Term Comparison of the Implantable Cardioverter Defibrillator Versus Amiodarone: Eleven-Year Follow-Up of a Subset of Patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation 2004; 110(2): 112–116.

91. Moss AJ, Hall WJ, Cannom DS et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia (MADIT). N Engl J Med 1996; 335: 1933–1940.

92. Moss AJ, Zareba W, Hall J et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877–83.

93. Buxton AE, Lee KL, Fischer JD et al. A randomized study of the prevention of sudden death in patients with coronary artery disease (MUSTT). N Engl J Med 1999; 341: 1882–1890.

94. Bardy GH, Lee KL, Mark DB, Poole JE et al. The Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an Implantable Cardioverter-Defibrillator for Congestive Heart Failure. N Engl J Med 2005; 352: 225-237.

95. Winters SL, Packer DL, Marchlinski FE et al. Consensus statement on indications, guidelines for use, and recommendations for follow-up of implantable cardioverter defibrillators. PACE 2001; 24: 262-269. 

96. Gregoratos G, Abrams J, Epstein AE et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002; 106: 2145-2161. 

97. Bernstein AD, Irwin ME, Parsonnet V et al. Report of the NASPE Policy Conference on antibradycardia pacemaker follow-up: Effectiveness, needs, and resources. North American Society of Pacing and Electrophysiology. PACE 1994; 17: 1714-1729.

98. Hutten H. Evaluation of an advanced cardiac telemonitoring system for multicenter studies based on data transmission via internet. Prog Biomed Res 1999; 4: 221-224.

99. Hutten H, Schreier G, Kastner P. Cardiac telemonitoring using pacemakers and the Internet. Medical & Biological Engineering & Computing 1999; 35 (Suppl 2): 1295.